Brian Philip

Brian Philip is a Principal Scientist specializing in Cell and Gene Therapy at the NIBRT CONCEPT facility, having joined in October 2023. Previously, Brian served as a Cellular Immunotherapy Consultant and Associate Director of Allogeneic Immunotherapy at Triumvira Immunologics, Inc. from February 2021 to September 2023. Brian's earlier roles include Research Associate at The University of Edinburgh, where contributions focused on advancing cellular therapies for malignancies and infections, and Senior Product Development Manager for CAR T-cells at TC BioPharm Limited, highlighting developments in T-cell engineering. Brian completed a PhD at UCL, researching T-cell cancer immunotherapy, and also holds a Master's degree in Microbiology from Birkbeck, University of London.